On 05 May 2021, Novo Nordisk A/S will announce the Q1 2021 results before the opening of the NASDAQ Copenhagen stock exchange.
A conference call will follow the announcement at:
13.00-14.00 (CET), 12.00-13.00 (BST), 07.00-08.00 (EST)
Please access the conference call using one of the following numbers
and the confirmation code:
Denmark: +45 3544 5577
UK and international: +44 333 300 0804
USA: +1 631 913 1422
Confirmation code: 39488831#
If you have any questions, you are welcome to contact Novo Nordisk
Investor Relations:
Daniel Muusmann Bohsen: +45 3075 2175
Valdemar Borum Svarrer: +45 3079 0301
Ann Søndermølle Rendbæk: +45 3075 2253
Mark Joseph Root : +45 3079 4211
Slides for the conference call will be available here approximately one hour before the event.
16 December: Decision to enter phase 3 development in Alzheimer’s disease and GLP-1 R&D strategy update
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
Investors
Share price
{{priceData.date}} {{priceData.time}}